ABOUT MALARIA

THE REALITY

One African child dies every 30 seconds from this parasitic disease.

Malaria is certainly the most catastrophic tropical disease. Spread throughout the tropics and many temperate areas, it’s devastating one third of the world's population and 40% percent of the world is at risk of infection.

Resistance to standard drugs, plus its prevalence and virulence, makes plasmodium by far the deadliest form of malarial infection.

Africa is losing its future generations: the majority of deaths are children under 5 years and pregnant women; 90% of deaths are in sub-Saharan Africa.

The scale and impact of the malaria pandemic keeps poor people poor and costs Africa $ 12 billion per year, in lost working time and morbidity.

THE VICTIMS ARE THE MOST VULNERABLE

THE CULPRIT

The parasites, plasmodium, are transmitted by mosquito: they infect humans by entering the blood stream when the mosquito bite.

More than a disease, malaria has a devastating impact on the entire world's economy and our future generations. It is our responsibility to ACT NOW and take part in providing hope to humanity. Millenia Hope addresses this catastrophic public health challenge by: •Developing effective medication against the parasite •Formulating a special children’s treatment •Partnering with international and local NGOs in order to reach afflicted populations •Creating a foundation to raise funds for those who cannot afford the medication

 

 

The international response to a worldwide catastrophe

Successful malaria control activities require coordinated actions by national authorities (especially the Ministries of Health), international organizations, governmental agencies and nongovernmental organizations, private sector and
the communities.

Roll Back Malaria (RBM) is a global partnership launched in 1998 by WHO, UNICEF, UNDP and the World Bank to provide a coordinated international approach to fight malaria and to improve health systems with the goal of a 50% reduction in malaria deaths by 2010. In fact, malaria has increased by 50% since 1998.

Financial efforts for malaria eradication

$942 million USD has been committed through the Global Fund to support malaria control over a five year period (Round 1, 2 and 3). Approximately 20-30% was spent on the purchase of pharmaceuticals. It is anticipated that a f u r t h e r $ 900 million USD could be mobilized for antimalarials (Round 4, June 2005).

Drug resistance in malaria

Global Strategic Plan - ROLL BACK
MALARIA 2005-2015